Get the Stockscreener App
6.37
3.41%
0.21
After Hours:
6.32
-0.05
-0.78%
P 3 Health Partners Inc Stock (PIII) Forecast
The P 3 Health Partners Inc (PIII) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.6375, representing a -74.29% decrease from the current price of $6.37. The highest analyst price target is $1.6442, and the lowest is $1.6308.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PIII Price Target
Average 1.6373
(-74.30% Downside)
Is P 3 Health Partners Inc (PIII) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.99 | Neutral |
| STOCH(9,6) | 34.25 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.4559 | Buy |
| ADX(14) | 36.87 | Sell |
| William %R | -66.80 | Neutral |
| CCI(14) | -4.3051 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.486
Buy
|
6.5833
Buy
|
| MA20 |
6.8575
Sell
|
6.9048
Sell
|
| MA50 |
7.9544
Sell
|
7.72
Sell
|
| MA100 |
8.6879
Sell
|
9.1798
Sell
|
| MA200 |
12.30
Sell
|
14.02
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, PIII could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on PIII, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.99 indicates that PIII is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.25 indicates that PIII is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that PIII is oversold. This suggests that PIII price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 36.87 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -4.3051 indicates that PIII is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PIII price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about P 3 Health Partners Inc financial reports and earnings history, P 3 Health Partners Inc (PIII) stock could reach $7.4682 by 2030, $5.1112 by 2040 and $18.57 by 2050. See the projected annual prices until 2050 of the P 3 Health Partners Inc stock below:
- P 3 Health Partners Inc (PIII) is expected to reach an average price of $19.38 in 2035, with a high prediction of $19.27 and a low estimate of $19.74. This indicates an $204.18% rise from the last recorded price of $6.37.
- P 3 Health Partners Inc (PIII) stock is projected to chart a bullish course in 2040, with an average price target of $4.7718, representing an $-25.09% surge from its current level. The forecast ranges from a conservative $4.7918 to a sky-high $5.1112.
- Our analysts predict P 3 Health Partners Inc (PIII) to jump 66.35% by 2045, soaring from $10.74 to an average price of $10.60, potentially reaching $11.25. While $10.74 is the low estimate, the potential upside is significant.
- P 3 Health Partners Inc (PIII) stock is expected to climb by 2050, reaching an average of $18.46, a $189.87% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.57 and $18.62, respectively, highlighting the market's uncertainty.
P 3 Health Partners Inc Stock (PIII) Year by Year Forecast
P 3 Health Partners Inc Stock (PIII) Price Forecast for 2025
P 3 Health Partners Inc Stock (PIII) is expected to reach an average price of $1.6903 in 2025, with a high prediction of $3.3777 and a low estimate of $0.00295. This indicates an -73.46% fall from the last recorded price of $6.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $1.652 | $1.6308 | $1.6442 | -74.07% |
| August, 2025 | $1.6033 | $1.7019 | $1.7678 | -74.83% |
| September, 2025 | $1.8136 | $1.731 | $1.7847 | -71.53% |
| October, 2025 | $1.2436 | $1.4136 | $1.4724 | -80.48% |
| November, 2025 | $1.0851 | $0.00295 | $2.03 | -82.96% |
| December, 2025 | $1.1361 | $0.9761 | $3.2717 | -82.17% |
P 3 Health Partners Inc Stock (PIII) Price Forecast for 2026
The predicted value for P 3 Health Partners Inc (PIII) in 2026 is set at an average of $0.6946. Estimates vary from a peak of $1.3883 to a trough of $0.000892, indicating an -89.10% surge from the present price of $6.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.2748 | $0.2348 | $1.3883 | -95.69% |
| February, 2026 | $0.0136 | $0.0164 | $0.8136 | -99.79% |
| March, 2026 | $0.2823 | $0.0823 | $0.4423 | -95.57% |
| April, 2026 | $0.1933 | $0.1345 | $1.1657 | -96.97% |
| May, 2026 | $0.118 | $0.1446 | $0.2454 | -98.15% |
| June, 2026 | $0.2493 | $0.1258 | $0.0993 | -96.09% |
| July, 2026 | $0.0683 | $0.2227 | $0.1549 | -98.93% |
| August, 2026 | $0.0804 | $0.00605 | $0.5539 | -98.74% |
| September, 2026 | $0.0714 | $0.0399 | $0.318 | -98.88% |
| October, 2026 | $0.2601 | $0.0835 | $0.3601 | -95.92% |
| November, 2026 | $0.0959 | $0.0394 | $0.3767 | -98.50% |
| December, 2026 | $0.081 | $0.000892 | $0.161 | -98.73% |
P 3 Health Partners Inc Stock (PIII) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for P 3 Health Partners Inc (PIII) is $2.9065, with a high forecast of $4.4853 and a low forecast of $1.3278. This indicates an -54.37% decrease from the last price of $6.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.4609 | $4.9696 | $4.4853 | -29.97% |
| February, 2027 | $3.8234 | $4.2334 | $4.0365 | -39.98% |
| March, 2027 | $1.5915 | $2.2603 | $3.419 | -75.02% |
| April, 2027 | $1.524 | $1.3278 | $0.964 | -76.08% |
| May, 2027 | $3.6665 | $2.4296 | $2.2209 | -42.44% |
| June, 2027 | $4.4447 | $3.7034 | $3.409 | -30.23% |
| July, 2027 | $4.3372 | $4.3159 | $4.3072 | -31.91% |
| August, 2027 | $2.9497 | $3.3897 | $3.9228 | -53.69% |
| September, 2027 | $2.6178 | $2.3465 | $2.2153 | -58.90% |
| October, 2027 | $2.0703 | $2.0247 | $2.3184 | -67.50% |
| November, 2027 | $2.1628 | $2.4328 | $1.9016 | -66.05% |
| December, 2027 | $2.3409 | $2.1297 | $1.8141 | -63.25% |
P 3 Health Partners Inc Stock (PIII) Price Forecast for 2028
In 2028, P 3 Health Partners Inc (PIII) is projected to reach an average price of $2.5105, with a high projection of $4.6354 and a low estimate of $0.3856. This indicates an -60.59% fall from the last price of $6.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6334 | $2.0278 | $1.6184 | -58.66% |
| February, 2028 | $4.5259 | $3.4791 | $4.1803 | -28.95% |
| March, 2028 | $4.5841 | $4.6241 | $4.6085 | -28.04% |
| April, 2028 | $4.4066 | $4.5052 | $4.6354 | -30.82% |
| May, 2028 | $4.2247 | $4.4101 | $4.4593 | -33.68% |
| June, 2028 | $3.7572 | $3.9272 | $4.0803 | -41.02% |
| July, 2028 | $1.2997 | $1.4997 | $2.0785 | -79.60% |
| August, 2028 | $1.0879 | $0.3856 | $0.9834 | -82.92% |
| September, 2028 | $1.8204 | $1.4635 | $1.5405 | -71.42% |
| October, 2028 | $1.9529 | $1.9616 | $1.8116 | -69.34% |
| November, 2028 | $1.501 | $1.671 | $2.1249 | -76.44% |
| December, 2028 | $1.4835 | $1.5266 | $1.8679 | -76.71% |
P 3 Health Partners Inc Stock (PIII) Price Forecast for 2029
The 2029 price forecast for P 3 Health Partners Inc Stock (PIII) is $4.9811 on average, with a high prediction of $9.4129 and a low estimate of $0.5493. This represents an -21.80% decrease from the previous price of $6.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.5016 | $1.6416 | $1.6161 | -76.43% |
| February, 2029 | $1.5741 | $1.6241 | $1.5329 | -75.29% |
| March, 2029 | $1.3266 | $1.4966 | $1.5098 | -79.17% |
| April, 2029 | $1.0491 | $1.1235 | $1.0079 | -83.53% |
| May, 2029 | $0.8973 | $0.9173 | $0.9549 | -85.91% |
| June, 2029 | $0.5798 | $0.6498 | $0.8029 | -90.90% |
| July, 2029 | $0.6153 | $0.5667 | $0.4852 | -90.34% |
| August, 2029 | $0.6081 | $0.5493 | $0.6669 | -90.45% |
| September, 2029 | $9.3563 | $9.9294 | $9.4129 | +46.88% |
| October, 2029 | $8.6035 | $8.7035 | $8.8998 | +35.06% |
| November, 2029 | $6.1973 | $6.8661 | $7.377 | -2.71% |
| December, 2029 | $6.001 | $5.8692 | $5.441 | -5.79% |
P 3 Health Partners Inc Stock (PIII) Price Forecast for 2030
P 3 Health Partners Inc Stock (PIII) is expected to reach an average price of $6.8237 in 2030, with a high forecast of $8.3657 and a low forecast of $5.2817. This signifies an +7.12% surge from the last price of $6.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.1482 | $6.8745 | $7.4682 | +27.92% |
| February, 2030 | $8.632 | $7.9551 | $7.6285 | +35.51% |
| March, 2030 | $8.3957 | $8.4389 | $8.3657 | +31.80% |
| April, 2030 | $6.8795 | $7.3195 | $7.9492 | +8.00% |
| May, 2030 | $6.3867 | $6.1798 | $6.1129 | +0.26% |
| June, 2030 | $5.7105 | $5.697 | $6.0551 | -10.35% |
| July, 2030 | $5.3776 | $5.9442 | $5.4773 | -15.58% |
| August, 2030 | $5.6914 | $5.5445 | $5.2611 | -10.65% |
| September, 2030 | $5.8552 | $5.2817 | $4.8402 | -8.08% |
| October, 2030 | $7.4824 | $6.6686 | $7.3487 | +17.46% |
| November, 2030 | $7.5161 | $7.5561 | $7.5727 | +17.99% |
| December, 2030 | $7.2099 | $7.3085 | $7.5031 | +13.18% |
0.11%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):